ADAM BRAY DERMATOLOGY LTD

💤Zombieactive
08325506 · ltd · incorporated 2012-12-11
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Dec 2024
Net worth
£30.7k
book net assets
Opportunity
73/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
43 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
73/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £30,662

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
£31k
↑ 2616% YoY
Current Assets
£52k
↓ 6.9% YoY
Current Liabilities
£0£11k£22k£34k£45k£56kDec 2023Dec 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2024-12-312023-12-31
Total assets£52.4k£23.2k
Current assets£52.3k£56.2k
Net assets£30.7k£1.1k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (19 events)Click to expand
  1. 2025-09-22
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  2. 2025-05-07
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  3. 2024-06-24
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  4. 2023-07-20
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  5. 2022-07-18
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  6. 2022-02-18
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  7. 2022-02-18
    📄
    change-person-director-company-with-change-date
    officers · CH01
  8. 2022-02-18
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  9. 2022-02-18
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  10. 2021-09-22
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  11. 2020-09-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  12. 2020-01-16
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  13. 2020-01-16
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  14. 2020-01-16
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  15. 2020-01-16
    📄
    change-person-director-company-with-change-date
    officers · CH01
  16. 2019-12-19
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  17. 2019-12-19
    📄
    change-person-director-company-with-change-date
    officers · CH01
  18. 2012-12-11
    🏢
    Company incorporated
    As ADAM BRAY DERMATOLOGY LTD
  19. 2012-12-11
    BRAY, Adam Peter James Jolyon appointed
    director

Owner dependency

95/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Founder name in company name: Company name contains director surname "BRAY" — strong identity link between founder and business.
  • +No director turnover: Company is 13 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

58/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • secondary12+ year tenure: Director in role 13 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mr Adam Peter James Jolyon Bray
Individual · British · DOB 06/1979 · age 47
2550%
25-50% shares01/07/2016
Mrs Julia Bray
Individual · British · DOB 10/1979 · age 47
2550%
25-50% shares01/07/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · BS postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ABLE HANDS LTD
12854737 · est 2020 · no financials extracted
5y
ABUNDANCE CARE LIMITED
14463398 · est 2022 · no financials extracted
3y
ACCESSIBLE MOVES CIC
16609611 · est 2025 · no financials extracted
ACCURE HEALTH CONSULTANCY LTD
09491915 · est 2015 · no financials extracted
11y
ACESETTERS LTD
14653268 · est 2023 · no financials extracted
3y
ACHARYA ORTHOPAEDICS LIMITED
09694108 · est 2015 · no financials extracted
10y
ACL REHAB ONLINE LIMITED
13560683 · est 2021 · no financials extracted
4y
ADHVIK LIMITED
10247292 · est 2016 · no financials extracted
9y
AEGIS HEALTHCARE LTD
12222962 · est 2019 · no financials extracted
6y
AFRICA KNOWLEDGE TREE (AKT)
09364951 · est 2014 · no financials extracted
11y
AFRIVITA HEALTH LIMITED
16283895 · est 2025 · no financials extracted
1y
AFS DENTAL LIMITED
16182649 · est 2025 · no financials extracted
1y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2012-12-11
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities

Registered office

C/O Andow Ellis Trym Lodge
1 Henbury Road
Westbury On Trym
Bristol
BS9 3HQ
United Kingdom

Filing status

Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2027-04-14
Last: 2026-03-31

Officers (1 active · 0 resigned)

BRAY, Adam Peter James Jolyon
director · ~47y · appointed 2012-12-11
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (43 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-03-31
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-09-22
accounts-with-accounts-type-micro-entity
accounts · AA
2025-05-07
confirmation-statement-with-updates
confirmation-statement · CS01
2025-04-01
accounts-with-accounts-type-micro-entity
accounts · AA
2024-06-24
confirmation-statement-with-updates
confirmation-statement · CS01
2024-04-02
accounts-with-accounts-type-micro-entity
accounts · AA
2023-07-20
confirmation-statement-with-updates
confirmation-statement · CS01
2023-04-03
accounts-with-accounts-type-micro-entity
accounts · AA
2022-07-18
confirmation-statement-with-updates
confirmation-statement · CS01
2022-04-01
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2022-02-18
change-person-director-company-with-change-date
officers · CH01
2022-02-18
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2022-02-18
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2022-02-18
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-12-13